Integrating big data and actionable health coaching to optimize wellness

BMC Medicine

Nathan D Price¹  Jennifer C Lovejoy²  Leroy Hood¹ 

[1] Institute for Systems Biology, 401 Terry Avenue North, Seattle 98109, WA, USA;University of Washington, School of Public Health, Seattle, WA, USA

关键词: Gut microbiome;    Systems medicine;    P4 Medicine;    Actionable;    Health behavior change;    Whole-genome sequencing;    Personalized medicine;    Wellness;   

Others  :  1118679
DOI  :  10.1186/s12916-014-0238-7

 received in 2014-10-16, accepted in 2014-11-12,  发布年份 2015

【 摘 要 】

The Hundred Person Wellness Project (HPWP) is a 10-month pilot study of 100 ‘well’ individuals where integrated data from whole-genome sequencing, gut microbiome, clinical laboratory tests and quantified self measures from each individual are used to provide actionable results for health coaching with the goal of optimizing wellness and minimizing disease. In a commentary in BMC Medicine, Diamandis argues that HPWP and similar projects will likely result in ‘unnecessary and potential harmful over-testing’. We argue that this new approach will ultimately lead to lower costs, better healthcare, innovation and economic growth. The central points of the HPWP are: 1) it is focused on optimizing wellness through longitudinal data collection, integration and mining of individual data clouds, enabling development of predictive models of wellness and disease that will reveal actionable possibilities; and 2) by extending this study to 100,000 well people, we will establish multiparameter, quantifiable wellness metrics and identify markers for wellness to early disease transitions for most common diseases, which will ultimately allow earlier disease intervention, eventually transitioning the individual early on from a disease back to a wellness trajectory.

Please see related commentary: http://dx.doi.org/10.1186/s12916-014-0239-6 webcite.

【 授权许可】

   
2015 Hood et al.; licensee BioMed Central.

【 参考文献 】

• [1]Hood L, Flores M: A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol 2012, 29:613-624.
• [2]Hood L, Price ND: Demystifying disease, democratizing health care. Sci Transl Med 2014, 6:225ed5.
• [3]Diamandis EP: The hundred person wellness project and Google's baseline study: medical revolution or unnecessary and potentially harmful over-testing?BMC Med 2015, doi:10.1186/s12916-014-0239-6.
• [4]Bloss CS, Wineinger NE, Darst BF, Schork NJ, Topol EJ: Impact of direct-to-consumer genomic testing at long-term follow up. J Med Genet 2013, 50:393-400.
• [5]Collins RE, Wright AJ, Marteau TM: Impact of communicating personalized genetic risk information on perceived control over the risk: a systematic review. Genetics Med 2011, 13:273-277.
• [6]Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, Chen C, Cook-Deegan R, Farrer LA: REVEAL Study Group: Disclosure of APOE genotype for risk of Alzheimer’s disease. N Engl J Med 2009, 361:245-254.
• [7]Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG: American College of Medical Genetics and Genomics: ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013, 15:565-574.
• [8]Lautenbach DM, Christensen KD, Sparks JA, Green RC: Communicating genetic risk information for common disorders in the Era of genomic medicine. Ann Rev Genomics Hum Genet 2013, 14:491-513.